ESR1 and cancer: Lower mRNA expression in bulk RNA analysis could be due to either fewer ER-positive cancer cells, that could be reflected by lower ER percent positivity by immunohistochemistry (IHC), or to lower ER mRNA expression within ER-positive cells.